Description

Firokox Tablet

Firocoxib Chewable Tablet 227 mg

COX-2 Selective NSAID | Dogs Only | Smoky Chicken Flavour | Smart Breakable Technology

Manufactured/Marketed by:
Panav Bio-Tech Pvt. Ltd.

Country of Origin: India

Dosage form: Chewable tablet

Presentation: 1 × 6 Tablets (60 Tablets Box)

Ingredients & Composition:

Ingredient               Amount / Strength
Firocoxib                227 mg
Excipients               q.s.

Description / Action:

Firokox Tablet contains Firocoxib 227 mg, a COX-2 selective NSAID chewable tablet for pain, osteoarthritis and post-surgical inflammation in dogs

Selective COX-2 inhibitor approved by both European Union and US FDA for pain-free living and GI microbiome protection in dogs.

Key Highlights:

COX-2 Selective — Targets pain & inflammation while sparing the stomach, ensuring fewer GI side effects than traditional NSAIDs.

Trusted & Approved — US-FDA approved molecule backed by strong clinical safety and efficacy data.

Fast & Long-Lasting — Starts working within 1 hour and provides effective relief for 24 hours (once-daily dosing).

Smart Breakable Technology
Easy Dosing, High Acceptance — Breakable tablets for accurate dosing with a palatable smoky chicken flavour.

Proven Results — 93% dogs improved; 86% more active in a 1,000-dog OA clinical study.

Class:

COX-2 selective non-steroidal anti-inflammatory drug (NSAID)
Coxib analgesic and anti-inflammatory agent

Indication / Uses:

Osteoarthritis (OA) Management — Once-daily, long-term relief from stiffness, limping, reluctance to jump, and reduced mobility.

Post-Surgical Pain (Soft Tissue & Orthopaedic) — Effective when given pre-op and continued post-op; supports recovery in spay/neuter, mass removal, cruciate repair, fractures, and hip surgeries.

Dental & Oral Procedures: Controls pain and inflammation following dental extractions and oral surgeries.

Trauma & Acute Musculoskeletal Pain: Fast-acting relief in injuries, falls, sprains, and muscle strains.

Inflammation-Associated Fever: Helps manage fever linked to inflammatory conditions in dogs.

Dosage and administration:

Firocoxib chewable tablets may be administered with or without food. For approved firocoxib products, regulatory information recommends using the lowest effective dose for the shortest duration consistent with individual response.

Overdoses / Side effects / Contraindications / Warnings:

Possible adverse effects include vomiting, diarrhoea, decreased appetite, lethargy and gastrointestinal abnormalities.

NSAID-associated gastrointestinal, renal or hepatic adverse effects may occur.

Do not use in dogs with known hypersensitivity to firocoxib.

Avoid concurrent administration with other NSAIDs or corticosteroids.

Use cautiously in dogs with pre-existing gastrointestinal, renal, hepatic or cardiovascular disease.

Baseline and periodic laboratory monitoring should be considered during long-term NSAID therapy.

In overdose, contact a veterinarian immediately. Higher-dose firocoxib safety studies reported gastrointestinal, hepatic and other abnormalities.

Pharmaceutical precautions / Instructions:

For oral use in dogs only. Use under veterinary supervision.

Ensure accurate dosing according to body weight. Store in a cool and dry place. Protect from moisture and direct sunlight.

Keep out of reach of children.

Safety: Age / Pregnancy / Withdrawal:

Age: Use in dogs according to veterinary advice. FDA firocoxib studies and approvals include canine use; long-term safety data are specifically available in dogs over seven months of age.

Pregnancy/Lactation: Safety in pregnant, breeding or lactating dogs has not been established; use only after veterinary risk-benefit assessment.

Withdrawal: Not applicable for companion dogs.

Substitute: Firotail Tablets,